VANCOUVER, BC, May 12, 2023 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical-stage natural psychedelic drug development company, released its first quarter financial results and operational highlights for the period ended March 31, 2023. “We are pleased to report on another highly productive quarter,” said Benjamin Lightburn…
Source